These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 17259672)

  • 1. Professional societies and industry support: what is the quid pro quo?
    Kassirer JP
    Perspect Biol Med; 2007; 50(1):7-17. PubMed ID: 17259672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective: Conflict of interest and professional organizations: considerations and recommendations.
    Camilleri M; Parke DW
    Acad Med; 2010 Jan; 85(1):85-91. PubMed ID: 20042830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines.
    Cosgrove L; Bursztajn HJ; Krimsky S; Anaya M; Walker J
    Psychother Psychosom; 2009; 78(4):228-32. PubMed ID: 19401623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
    Kerridge I; Maguire J; Newby D; McNeill PM; Henry D; Hill S; Day R; Macdonald G; Stokes B; Henderson K
    Intern Med J; 2005 Apr; 35(4):206-10. PubMed ID: 15836497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical advertising revenue and physician organizations: how much is too much?
    Glassman PA; Hunter-Hayes J; Nakamura T
    West J Med; 1999 Oct; 171(4):234-8. PubMed ID: 10578674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry.
    Henry D; Doran E; Kerridge I; Hill S; McNeill PM; Day R
    Arch Intern Med; 2005 Nov; 165(21):2493-6. PubMed ID: 16314546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society.
    Finucane TE; Boult CE
    Am J Med; 2004 Dec; 117(11):842-5. PubMed ID: 15589488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-industry relations. Part 2: organizational issues.
    Coyle SL;
    Ann Intern Med; 2002 Mar; 136(5):403-6. PubMed ID: 11874315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgeon-industry conflict of interest: survey of opinions regarding industry-sponsored educational events and surgeon teaching: clinical article.
    DiPaola CP; Dea N; Dvorak MF; Lee RS; Hartig D; Fisher CG
    J Neurosurg Spine; 2014 Mar; 20(3):313-21. PubMed ID: 24359001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry influence in the creation of pay-for-performance quality measures.
    Rose J
    Qual Manag Health Care; 2008; 17(1):27-34. PubMed ID: 18204375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Professionalism and physician interactions with industry.
    Collins J
    J Am Coll Radiol; 2006 May; 3(5):325-32. PubMed ID: 17412075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia.
    McNeill PM; Kerridge IH; Henry DA; Stokes B; Hill SR; Newby D; Macdonald GJ; Day RO; Maguire J; Henderson KM
    Intern Med J; 2006 Sep; 36(9):571-8. PubMed ID: 16911549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry support of graduate medical education in surgery.
    Nakayama DK; Bozeman AP
    Am Surg; 2009 May; 75(5):395-400. PubMed ID: 19445290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer.
    Norris R; Bowman A; Fagan JM; Gallagher ER; Geraci AB; Gertel A; Hirsch L; Ross PD; Stossel TP; Veitch K; Woods D
    Curr Med Res Opin; 2007 Aug; 23(8):1837-40. PubMed ID: 17605897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies' websites.
    Fabbri A; Gregoraci G; Tedesco D; Ferretti F; Gilardi F; Iemmi D; Lisi C; Lorusso A; Natali F; Shahi E; Rinaldi A
    BMJ Open; 2016 Jun; 6(6):e011124. PubMed ID: 27251686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of the pharmaceutical industry on treatment guidelines].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatricians and the pharmaceutical industry: an industry perspective of the challenges ahead.
    Leather DA; Davis SC
    Paediatr Respir Rev; 2006 Mar; 7(1):60-6. PubMed ID: 16473819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary: Disclosure's failings: what is the alternative?
    Kassirer JP
    Acad Med; 2009 Sep; 84(9):1180-1. PubMed ID: 19707054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.